In today’s recent session, 0.9 million shares of the Predictive Oncology Inc (NASDAQ:POAI) have been traded, and its beta is 1.19. Most recently the company’s share price was $0.78, and it changed around -$0.07 or -8.55% from the last close, which brings the market valuation of the company to $6.94M. POAI at last check was trading at a discount to its 52-week high of $3.06, offering almost -292.31% off that amount. The share price’s 52-week low was $0.55, which indicates that the recent value has risen by an impressive 29.49% since then. We note from Predictive Oncology Inc’s average daily trading volume that its 10-day average is 0.11 million shares, with the 3-month average coming to 158.87K.
Predictive Oncology Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended POAI as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Predictive Oncology Inc (NASDAQ:POAI) trade information
Instantly POAI has been showing red trend so far today with a performance of -8.55% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8700 on recent trading dayincreased the stock’s daily price by 10.34%. The company’s shares are currently down -23.04% year-to-date, but still down -6.35% over the last five days. On the other hand, Predictive Oncology Inc (NASDAQ:POAI) is -18.18% down in the 30-day period. We can see from the shorts that 0.11 million shares have been sold at a short interest cover period of 0.47 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 56.10%.
POAI Dividends
Predictive Oncology Inc’s next quarterly earnings report is expected to be released on 2025-May-14.
Predictive Oncology Inc (NASDAQ:POAI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.27% of Predictive Oncology Inc shares, and 2.07% of them are in the hands of institutional investors. The stock currently has a share float of 2.10%. Predictive Oncology Inc stock is held by 16.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 1.5286% of the shares, which is about 71307.0 shares worth $74159.0.
GEODE CAPITAL MANAGEMENT, LLC, with 0.8775% or 40932.0 shares worth $42578.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 69.88 shares worth $55562.0, making up 0.78% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 36.17 shares worth around $28761.0, which represents about 0.40% of the total shares outstanding.
